DETERMINATION OF THE COMPOSITION OF DELAVIRDINE MESYLATE POLYMORPH AND PSEUDOPOLYMORPH MIXTURES USING C-13 CP MAS NMR/

Authors
Citation
P. Gao, DETERMINATION OF THE COMPOSITION OF DELAVIRDINE MESYLATE POLYMORPH AND PSEUDOPOLYMORPH MIXTURES USING C-13 CP MAS NMR/, Pharmaceutical research, 13(7), 1996, pp. 1095-1104
Citations number
20
Categorie Soggetti
Pharmacology & Pharmacy",Chemistry
Journal title
ISSN journal
07248741
Volume
13
Issue
7
Year of publication
1996
Pages
1095 - 1104
Database
ISI
SICI code
0724-8741(1996)13:7<1095:DOTCOD>2.0.ZU;2-J
Abstract
Purpose. The application of solid-state nuclear magnetic resonance for the quantitation of relative amounts of delavirdine mesylate (DLV-M) polymorph and/or pseudopolymorph in their binary mixtures is presented . Methods. C-13 CP (cross-polarization)/MAS (magic angle spinning) NMR techniques were employed for quantitation. Results. C-13 CP/MAS NMR s pectra of three DLV-M solid forms (VIII, XI, and XII) revealed distinc t differences in chemical shifts and peak splitting characteristics. R esonances of isopropyl methyl carbons of DLV-M were diagnostic of each form; resonance intensities were utilized to determine the compositio n of two series of DLV-M solid form mixtures (VIII and XI; XII and XI) over a dynamic concentration range (1-50%). The empirical detection l imit of form VIII, or XII, in a dominant form XI environment was about 2-3% (w/w). Quantitations were obtained using appropriate analytical procedures, which took into account the differences of T-CH and T-1pH between the two forms. Quantitative results obtained using either the peak area or peak height were examined, and, in general, were satisfac tory. Conclusions. The methodology and analytical procedure developed in this study are generally applicable to quantitative analysis using C-13 CP/MAS NMR for pharmaceutical solids, including bulk drug substan ces, and dosage forms. Reliable measurement of NMR relaxation times (T -1pH) and CP rate constants (T-CH) Of individual forms is a critical c omponent in this application.